Looking after business development and licensing, and market access globally since 2011
MEMORANDUM OF IVANOV, IGOR
CEO AND MANAGING PARTNER, PHARMALICENSING ONE, LLC
August 14th, 2023
Russian Pharmalicensing Group, LLC (RPhG), established in 2011, moved its headquarter and launched its re-branding since 2023.
In August 2023, due to ongoing global eventsdevelopments in the world, we made a strategic decision to set up a new legal entity called Pharmalicensing ONE, LLC (PhL1) in Bishkek, Kyrgyz Republic. Nowadays, Kyrgyz Republic is a former USSR republic, and one of the most innovation-oriented nations in Central Asia. Experts greatly appreciate conducive and productive business climate for multiple industries.
Рharmalicensing ONE (PhL1) will continue to provide BD&L, M&A advisory, and MA consulting to its international clientele.
Рharmalicensing ONE (PhL1) is a successor of Russian Pharmalicensing Group, LLC (RPhG), established in Moscow by Mr. KRASNIKOV, Vladimir, who enriched the company with 30+ years of business experience in marketing and sales management, BD&L, RA and МА at Fortune 500 companies (Johnson & Johnson, Roche, GE, and Glenmark).
2023 became a milestone for our company. We experienced a growth for our services in the first half of the year when the international pharma industry demonstrated a bounce-back in sales after the completion of COVID isolation got over. RPhG expanded its activities in 2017 – 2022 to match business demands of our partners, expanded its geographic business operationals coverage, successfully completed a number of BD&L projects in the EU, South America, South Africa, APAC, and ex-USSR (including RA and M&A). Productive and successful experience with our BD&L services coupled with our expansion in MENA, APAC, and RoW markets.
Our office in Bishkek, Kyrgyz Republic, will continue keep building momentum on that grow that trend.
Рharmalicensing ONE’s strategic goals for the next 5 years assume:
Let’s merge our efforts in business to boost your operations and results. We are keen to add more success to your projects.
IVANOV, Igor, CEO
Pharmalicensing One, LLC
141, Abdrakhmanova street
Bishkek 720021, Republic of Kyrgyzstan
Email: business@pharmalicensingone.com
In August 2023, due to ongoing global eventsdevelopments in the world, we made a strategic decision to set up a new legal entity called Pharmalicensing ONE, LLC (PhL1) in Bishkek, Kyrgyz Republic. Nowadays, Kyrgyz Republic is a former USSR republic, and one of the most innovation-oriented nations in Central Asia. Experts greatly appreciate conducive and productive business climate for multiple industries.
Рharmalicensing ONE (PhL1) will continue to provide BD&L, M&A advisory, and MA consulting to its international clientele.
Рharmalicensing ONE (PhL1) is a successor of Russian Pharmalicensing Group, LLC (RPhG), established in Moscow by Mr. KRASNIKOV, Vladimir, who enriched the company with 30+ years of business experience in marketing and sales management, BD&L, RA and МА at Fortune 500 companies (Johnson & Johnson, Roche, GE, and Glenmark).
2023 became a milestone for our company. We experienced a growth for our services in the first half of the year when the international pharma industry demonstrated a bounce-back in sales after the completion of COVID isolation got over. RPhG expanded its activities in 2017 – 2022 to match business demands of our partners, expanded its geographic business operationals coverage, successfully completed a number of BD&L projects in the EU, South America, South Africa, APAC, and ex-USSR (including RA and M&A). Productive and successful experience with our BD&L services coupled with our expansion in MENA, APAC, and RoW markets.
Our office in Bishkek, Kyrgyz Republic, will continue keep building momentum on that grow that trend.
Рharmalicensing ONE’s strategic goals for the next 5 years assume:
- Expanding our clientele.
- Local markets benchmarking.
- Leveraging operations, including acquisitions of marketing rights for Central Asia and RoW markets.
- Business development in growth territories (MENA and APAC).
- Building a sustained competitive advantage through going international.
Let’s merge our efforts in business to boost your operations and results. We are keen to add more success to your projects.
IVANOV, Igor, CEO
Pharmalicensing One, LLC
141, Abdrakhmanova street
Bishkek 720021, Republic of Kyrgyzstan
Email: business@pharmalicensingone.com
Business
Pharmalicensing One, LLC (acrn.: PhL1) is an independent advisory boutique headquartered in Bishkek, Republic of Kyrgyzstan.
PhL1’s business expertise areas are Pharmaceutical Licensing & Asset scouting, M&A advisory, and Consulting in pharmaceutical industry.
Our customers are international pharmaceutical / biotech / medical device companies looking for ways to establish a footprint or strategic alliance in their target markets.
We support both multinational and mid-size pharma companies with their license IN/OUT search and evaluation activities to ensure that partnership, licensing and investment decisions are taken with confidence.
We help companies create sustained strategic partnerships via IN- and OUT-licensing of technologies, compounds, and products at all stages of development (R&D) worldwide.
PhL1 permanently expands its activities to match business demands of our partners, expanded its geographic business operationals coveragein the EU, South America, South Africa, MENA, APAC, and ex-USSR.
PhL1’s business expertise areas are Pharmaceutical Licensing & Asset scouting, M&A advisory, and Consulting in pharmaceutical industry.
Our customers are international pharmaceutical / biotech / medical device companies looking for ways to establish a footprint or strategic alliance in their target markets.
We support both multinational and mid-size pharma companies with their license IN/OUT search and evaluation activities to ensure that partnership, licensing and investment decisions are taken with confidence.
We help companies create sustained strategic partnerships via IN- and OUT-licensing of technologies, compounds, and products at all stages of development (R&D) worldwide.
PhL1 permanently expands its activities to match business demands of our partners, expanded its geographic business operationals coveragein the EU, South America, South Africa, MENA, APAC, and ex-USSR.
2011-2025
2014
2011
2014-2018
2023
2018
Russian Pharmalicensing Group, LLC (RPhG) established in Moscow, fully owned and lead by Dr. KRASNIKOV, Vladimir.
Facilitated 100+ in/out-licensing deals in ex-USSR, including company acquisitions.
Established operations in Bosnia to start business in the Balkans.
Further market expansion internationally. In/out-licensing deals concluded (biosimilars, generics, and original products) in the EU (18 markets in the EU active), UK, ANZ, South America, Israel, South Africa.
RPhG shifted business to a new company in Kyrgyzstan - Pharmalicensing One, LLC established in Bishkek.
Started regulatory and PhV services to our clients in pharma, medical device, medical food, cosmetics, and dietary supplements businesses in ex-USSR.
OUR HISTORY
Corporate Responsibility
At PhL1, our mission is to deliver high-quality and turn-key solutions to empower our clients make strategic corporate decisions.
Our Company culture is founded on the principles of Trust, Integrity, Transparency, Leadership and Self-Development. Of those principles, Trust and Transparency are among the most important: Trust in collaboration with our clients, the Integrity of our team and business processes, the character of our people, and the benefit to medical community and society.
We strive to implement those values in our work to make best for our clients. Look up next how we do that.
Our Company culture is founded on the principles of Trust, Integrity, Transparency, Leadership and Self-Development. Of those principles, Trust and Transparency are among the most important: Trust in collaboration with our clients, the Integrity of our team and business processes, the character of our people, and the benefit to medical community and society.
We strive to implement those values in our work to make best for our clients. Look up next how we do that.
